Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 1516 AL 1530

Protective effect of resveratrol derived from Polygonum cuspidatum and its liposomal form on nigral cells in parkinsonian rats

Wang Y, Xu H, Fu Q, Ma R, Xiang J.

J Neurol Sci. 2011 May 15;304(1-2):29-34. doi: 10.1016/j.jns.2011.02.025. Epub 2011 Mar 3.

Dopamine agonists in animal models of Parkinson's disease: a systematic review and meta-analysis

Rooke ED, Vesterinen HM, Sena ES, Egan KJ, Macleod MR.

Parkinsonism Relat Disord. 2011 Jun;17(5):313-20. doi: 10.1016/j.parkreldis.2011.02.010. Epub 2011 Mar 4.

HDAC6 α-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases

Li G, Jiang H, Chang M, Xie H, Hu L.

J Neurol Sci. 2011 May 15;304(1-2):1-8. doi: 10.1016/j.jns.2011.02.017. Epub 2011 Mar 5.

Genetic mouse models of neurodegenerative diseases

Trancikova A, Ramonet D, Moore DJ.

Prog Mol Biol Transl Sci. 2011;100:419-82. doi: 10.1016/B978-0-12-384878-9.00012-1.

Watching worms whither: modeling neurodegeneration in C. elegans

Wolozin B, Gabel C, Ferree A, Guillily M, Ebata A.

Prog Mol Biol Transl Sci. 2011;100:499-514. doi: 10.1016/B978-0-12-384878-9.00015-7.

Mild parkinsonian signs in a community-dwelling elderly population sample in Japan

Uemura Y, Wada-Isoe K, Nakashita S, Nakashima K.

J Neurol Sci. 2011 May 15;304(1-2):61-6. doi: 10.1016/j.jns.2011.02.013. Epub 2011 Mar 5.

Novel mutations in SPG11 cause hereditary spastic paraplegia associated with early-onset levodopa-responsive Parkinsonism

Guidubaldi A, Piano C, Santorelli FM, Silvestri G, Petracca M, Tessa A, Bentivoglio AR.

Mov Disord. 2011 Feb 15;26(3):553-6. doi: 10.1002/mds.23552. Epub 2011 Mar 4.

Walking patterns in Parkinson's disease with and without freezing of gait

Nanhoe-Mahabier W, Snijders AH, Delval A, Weerdesteyn V, Duysens J, Overeem S, Bloem BR.

Neuroscience. 2011 May 19;182:217-24. doi: 10.1016/j.neuroscience.2011.02.061. Epub 2011 Mar 5.

Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: a review

Broen M, Duits A, Visser-Vandewalle V, Temel Y, Winogrodzka A.

Parkinsonism Relat Disord. 2011 Jul;17(6):413-7. doi: 10.1016/j.parkreldis.2011.02.013. Epub 2011 Mar 5.

[Surgical targets in Psychiatric disorders. From movement to emotions]

Guridi J, Aldave G.

Neurocirugia (Astur). 2011 Feb;22(1):5-22.

Association study between four polymorphisms in the HFE, TF and TFR genes and Parkinson's disease in southern Italy

Greco V, De Marco EV, Rocca FE, Annesi F, Civitelli D, Provenzano G, Tarantino P, Scornaienchi V, Pucci F, Salsone M, Novellino F, Morelli M, Paglionico S, Gambardella A, Quattrone A, Annesi G.

Neurol Sci. 2011 Jun;32(3):525-7. doi: 10.1007/s10072-011-0504-9. Epub 2011 Mar 8.

Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale

Leentjens AF, Dujardin K, Marsh L, Richard IH, Starkstein SE, Martinez-Martin P.

Mov Disord. 2011 Feb 15;26(3):407-15. doi: 10.1002/mds.23184. Epub 2011 Mar 7.

Parkinson's syndrome and Parkinson's disease in mitochondrial disorders

Finsterer J.

Mov Disord. 2011 Apr;26(5):784-91. doi: 10.1002/mds.23651. Epub 2011 Mar 7.

Multidisciplinary care for Parkinson's disease: not if, but how!

Post B, van der Eijk M, Munneke M, Bloem BR.

Pract Neurol. 2011 Apr;11(2):58-61. doi: 10.1136/jnnp.2011.241604.

Adenosine A(2A) receptors measured with [C]TMSX PET in the striata of Parkinson's disease patients

Mishina M, Ishiwata K, Naganawa M, Kimura Y, Kitamura S, Suzuki M, Hashimoto M, Ishibashi K, Oda K, Sakata M, Hamamoto M, Kobayashi S, Katayama Y, Ishii K.

PLoS One. 2011 Feb 28;6(2):e17338. doi: 10.1371/journal.pone.0017338.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias